Uppsala: Researchers at Uppsala University and KTH Royal Institute of Technology have created an antibody that has the potential to treat a variety of cancers. Researchers were able to integrate three different functionalities in the antibody, which combined significantly increased the action of T cells on the cancer tumour.
Researchers have developed a unique type of antibody that both targets and delivers a drug package via the antibody itself, while simultaneously activating the immune system ("3-in-1 design") for personalised immunotherapy treatments.
